v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES:    
Consolidated net loss $ (7,401,558) $ (20,070,150)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 5,102,643 12,702,552
Stock-based compensation 674,988 690,350
Stock-based compensation - consultant 702,488 462,735
Unrealized (gain) loss on marketable securities (335,493) 78,406
Loss on disposition of assets 1,219,913
Gain on conversion of debt 595,672
Noncash interest charges 3,635,842 2,805,481
Interest on notes receivable (14,773) (46,771)
Changes in operating assets and liabilities:    
Accounts receivable (7,897,623) (17,309,724)
Prepaid expenses 241,121 (1,583,825)
Inventories 73,205
Right of use assets - operating leases 302,986 1,085,126
Other assets 169,957 (155,984)
Accounts payable and accrued expenses 2,053,562 14,297,080
Accrued compensation 444
Operating lease liabilities (302,985) (1,228,730)
Net cash provided by (used in) operating activities (3,664,073) (6,980,336)
INVESTING ACTIVITIES:    
Proceeds from sale of property and equipment 1,860,000
Investment in joint venture (500,000)
Net cash provided by (used in) investing activities (500,000) 1,860,000
FINANCING ACTIVITIES:    
Payment on financing lease liabilities (75,294) (1,222,045)
Proceeds from loans and notes payable 7,190,365 10,396,612
Proceeds from loans and notes payable - related party 1,911,432
Payment of notes payable (4,254,772) (4,812,898)
Payment of notes payable - related party (532,374) (1,164,601)
Net cash provided by (used in) financing activities 2,327,925 5,108,500
Net increase (decrease) in cash and cash equivalents (1,836,148) (11,836)
CASH AND CASH EQUIVALENTS, and CASH RESTRICTED, BEGINNING OF PERIOD 2,095,896 3,676,992
CASH AND CASH EQUIVALENTS, and CASH RESTRICTED, END OF PERIOD 259,749 3,665,156
Cash paid during the year for:    
Interest 1,719,037
Noncash transactions:    
Accounts payable on purchase of equipment 1,433,463
Notes payable settled against working capital items for netting arrangement 10,203,666
Series A preferred shareholder stock dividends 3,649,241 3,045,037
Common stock issued with debt $ 1,086,963
Common stock issued for a reduction in liabilities 754,642
Common stock issued on conversion of debt $ 4,124,705